JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ladomery, M. R.
Right arrow Articles by Hastie, N. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ladomery, M. R.
Right arrow Articles by Hastie, N. D.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 274, Issue 51, 36520-36526, December 17, 1999

Presence of WT1, the Wilm's Tumor Suppressor Gene Product, in Nuclear Poly(A)+ Ribonucleoprotein*

Michael R. Ladomery, Joan Slight, Sharon Mc Ghee, and Nicholas D. HastieDagger

From the MRC Human Genetics Unit, Western General Hospital, Crewe Road, Edinburgh EH4 2XU, Scotland, United Kingdom

The tumor suppressor gene WT1 encodes a zinc finger protein, which consists of four C-terminal C2-H2 zinc fingers of the Krüppel type, and at the N terminus a Q/P-rich trans-regulatory domain, both characteristic of transcription factors. However, recent findings suggest that WT1 may also be involved in a post-transcriptional process. Specifically, WT1 isoforms containing the alternatively spliced exon 9 (+lysine-threonine-serine (KTS)) preferentially associate with nuclear speckles and co-immunoprecipitate splicing antigens (Larsson, S. H., Charlieu, J.-P., Miyagawa, K., Engelkamp, D., Rassoulzadegan, M., Ross, A., Cuzin, F., van Heyningen, V., and Hastie, N. D. (1995) Cell 81, 391-401); furthermore, WT1 has been shown to interact with the ubiquitous splicing factor U2AF65 (Davies, R. C., Calvo, C., Larsson, S. H., Lamond, A. I., and Hastie, N. D. (1998) Genes Dev. 12, 3217-3225) and binds to RNA in vitro (Caricasole, A., Duarte, A., Larsson, S. H., Hastie, N. D., Little, M., Holmes, G., Todorov, I., and Ward, A. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 7562-7566; Bardeesy, N., and Pelletier, J. (1998) Nucleic Acids Res. 26, 1784-1792). To extend these findings, we have fractionated nuclear extracts to see if particles containing WT1 have the properties of ribonucleoprotein (RNP). In summary, WT1 is enriched by oligo(dT) chromatography, as are U2AF65, the U5 small nuclear RNP-associated protein p116 and hnRNP A1. Gel filtration and sedimentation profiles suggest that WT1 is present in RNase-sensitive particles, >2 MDa in size, peaking at ~60 S, and ~1.27 g/cm3 on Nycodenz. Similar results were obtained from two cell lines expressing WT1, fetal kidneys (day E17), and transiently transfected cells, suggesting that the presence of WT1 protein in nuclear poly(A)+ RNP is a general aspect of WT1 function.


* This work was supported by a grant from the National Kidney Research Foundation and the Medical Research Council.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed. Tel.: 0131-3322471; Fax: 0131-3432620; E-mail: Nick.Hastie@hgu.mrc.ac.uk.


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
A. A. Morrison, R. L. Viney, M. A. Saleem, and M. R. Ladomery
New insights into the function of the Wilms tumor suppressor gene WT1 in podocytes
Am J Physiol Renal Physiol, July 1, 2008; 295(1): F12 - F17.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
Y. Bor, J. Swartz, A. Morrison, D. Rekosh, M. Ladomery, and M.-L. Hammarskjold
The Wilms' tumor 1 (WT1) gene (+KTS isoform) functions with a CTE to enhance translation from an unspliced RNA with a retained intron
Genes & Dev., June 15, 2006; 20(12): 1597 - 1608.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
N. Wagner, K.-D. Wagner, H. Theres, C. Englert, A. Schedl, and H. Scholz
Coronary vessel development requires activation of the TrkB neurotrophin receptor by the Wilms' tumor transcription factor Wt1
Genes & Dev., November 1, 2005; 19(21): 2631 - 2642.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
N. Wagner, K.-D. Wagner, A. Hammes, K. M. Kirschner, V. P. Vidal, A. Schedl, and H. Scholz
A splice variant of the Wilms' tumour suppressor Wt1 is required for normal development of the olfactory system
Development, March 15, 2005; 132(6): 1327 - 1336.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
M. Niksic, J. Slight, J. R. Sanford, J. F. Caceres, and N. D. Hastie
The Wilms' tumour protein (WT1) shuttles between nucleus and cytoplasm and is present in functional polysomes
Hum. Mol. Genet., February 15, 2004; 13(4): 463 - 471.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
M. T. Discenza and J. Pelletier
Insights into the physiological role of WT1 from studies of genetically modified mice
Physiol Genomics, February 13, 2004; 16(3): 287 - 300.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
B. Carpenter, K. J. Hill, M. Charalambous, K. J. Wagner, D. Lahiri, D. I. James, J. S. Andersen, V. Schumacher, B. Royer-Pokora, M. Mann, et al.
BASP1 Is a Transcriptional Cosuppressor for the Wilms' Tumor Suppressor Protein WT1
Mol. Cell. Biol., January 15, 2004; 24(2): 537 - 549.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
J. A. Davies, M. Ladomery, P. Hohenstein, L. Michael, A. Shafe, L. Spraggon, and N. Hastie
Development of an siRNA-based method for repressing specific genes in renal organ culture and its use to show that the Wt1 tumour suppressor is required for nephron differentiation
Hum. Mol. Genet., January 15, 2004; 13(2): 235 - 246.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
K.-D. Wagner, N. Wagner, and A. Schedl
The complex life of WT1
J. Cell Sci., May 1, 2003; 116(9): 1653 - 1658.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
M. Ladomery, J. Sommerville, S. Woolner, J. Slight, and N. Hastie
Expression in Xenopus oocytes shows that WT1 binds transcripts in vivo, with a central role for zinc finger one
J. Cell Sci., April 15, 2003; 116(8): 1539 - 1549.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
C. G. Miles, J. Slight, L. Spraggon, M. O'Sullivan, C. Patek, and N. D. Hastie
Mice Lacking the 68-Amino-Acid, Mammal-Specific N-Terminal Extension of WT1 Develop Normally and Are Fertile
Mol. Cell. Biol., April 1, 2003; 23(7): 2608 - 2613.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
D. J. Richard, V. Schumacher, B. Royer-Pokora, and S. G.E. Roberts
Par4 is a coactivator for a splice isoform-specific transcriptional activation domain in WT1
Genes & Dev., February 1, 2001; 15(3): 328 - 339.
[Abstract] [Full Text]


Home page
J. Am. Soc. Nephrol.Home page
C. MROWKA and A. SCHEDL
Wilms' Tumor Suppressor Gene WT1: From Structure to Renal Pathophysiologic Features
J. Am. Soc. Nephrol., November 1, 2000; 11(90002): 106S - 115.
[Abstract] [Full Text]


Home page
Clin. Cancer Res.Home page
D. Baudry, M. Hamelin, M.-O. Cabanis, J.-C. Fournet, M.-F. Tournade, S. Sarnacki, C. Junien, and C. Jeanpierre
WT1 Splicing Alterations in Wilms' Tumors
Clin. Cancer Res., October 1, 2000; 6(10): 3957 - 3965.
[Abstract] [Full Text]


Home page
Hum Mol GenetHome page
N. A. Little, N. D. Hastie, and R. C. Davies
Identification of WTAP, a novel Wilms' tumour 1-associating protein
Hum. Mol. Genet., September 1, 2000; 9(15): 2231 - 2239.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.